Try Fund Library Premium
For Free with a 30 day trial!
Sector Equity
|
Close (01-28-2026) |
$7.46 |
|---|---|
| Change |
-$0.18
(-2.36%)
|
| Open | $7.62 |
|---|---|
| Day Range | $7.46 - $7.62 |
| Volume | 15,518 |
As at December 31, 2025
As at December 31, 2025
Loading...
Loading...
Inception Return (April 04, 2017): -13.68%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | -3.57% | -20.66% | 17.57% | -13.00% | -13.00% | -6.86% | -11.03% | -23.96% | -22.99% | -19.74% | -21.92% | -21.66% | - | - |
| Benchmark | 1.32% | 6.25% | 19.53% | 31.68% | 31.68% | 26.57% | 21.42% | 13.94% | 16.09% | 14.27% | 15.46% | 12.10% | 11.76% | 12.66% |
| Category Average | -1.55% | 9.84% | 9.84% | 15.55% | 15.55% | 17.95% | 20.75% | 7.11% | 8.71% | 11.99% | 13.42% | 11.86% | 12.78% | 11.38% |
| Category Rank | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Return % | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -2.95% | -3.80% | -16.69% | -2.71% | -0.96% | -1.25% | 7.90% | 31.66% | 4.31% | -12.56% | -5.89% | -3.57% |
| Benchmark | 3.48% | -0.40% | -1.51% | -0.10% | 5.56% | 2.91% | 1.69% | 4.96% | 5.40% | 0.97% | 3.86% | 1.32% |
51.51% (November 2020)
-23.82% (October 2018)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | -19.82% | -33.82% | -1.28% | -18.99% | -52.54% | -18.82% | -0.29% | -13.00% |
| Benchmark | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% | 21.65% | 31.68% |
| Category Average | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% | 20.41% | 15.55% |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
| Category Rank | - | - | - | - | - | - | - | - | - | - |
-0.29% (2024)
-52.54% (2022)
| Name | Percent |
|---|---|
| Canadian Equity | 43.69 |
| US Equity | 41.71 |
| International Equity | 14.14 |
| Cash and Equivalents | 0.46 |
| Name | Percent |
|---|---|
| Healthcare | 57.40 |
| Consumer Goods | 19.60 |
| Real Estate | 10.21 |
| Basic Materials | 7.26 |
| Technology | 2.05 |
| Other | 3.48 |
| Name | Percent |
|---|---|
| North America | 85.86 |
| Europe | 11.28 |
| Asia | 2.87 |
| Name | Percent |
|---|---|
| Jazz Pharmaceuticals PLC | 11.28 |
| Innovative Industrial Properties Inc | 10.21 |
| Cronos Group Inc | 9.89 |
| SNDL Inc | 9.25 |
| Tilray Brands Inc | 8.96 |
| Canopy Growth Corp | 7.24 |
| Silver Spike Investment Corp | 5.90 |
| Scotts Miracle-Gro Co | 5.51 |
| Aurora Cannabis Inc | 5.34 |
| High Tide Inc | 5.08 |
Global X Marijuana Life Sciences Index ETF Class A
Median
Other - Sector Equity
| Standard Deviation | 34.31% | 39.56% | - |
|---|---|---|---|
| Beta | 1.58% | 1.63% | - |
| Alpha | -0.38% | -0.44% | - |
| Rsquared | 0.26% | 0.25% | - |
| Sharpe | -0.29% | -0.54% | - |
| Sortino | -0.42% | -0.82% | - |
| Treynor | -0.06% | -0.13% | - |
| Tax Efficiency | - | 50.51% | - |
| Volatility |
|
|
- |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 41.74% | 34.31% | 39.56% | - |
| Beta | 2.85% | 1.58% | 1.63% | - |
| Alpha | -0.87% | -0.38% | -0.44% | - |
| Rsquared | 0.32% | 0.26% | 0.25% | - |
| Sharpe | -0.22% | -0.29% | -0.54% | - |
| Sortino | -0.41% | -0.42% | -0.82% | - |
| Treynor | -0.03% | -0.06% | -0.13% | - |
| Tax Efficiency | - | - | 50.51% | - |
| Start Date | April 04, 2017 |
|---|---|
| Instrument Type | Exchange Traded Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Quarterly |
| Assets ($mil) | - |
| 52 Week High | $10.50 |
| 52 Week Low | $5.77 |
| Annual Dividend | $0.14 |
| Annual Yield | - |
| Index | North American Medical Marijuana Index |
| Shares Outstanding | - |
| Registered Plan Eligible | Yes |
| Exposure | 1X performance |
|---|---|
| Asset Class High | - |
| Asset Class Medium | - |
| Asset Class Low | - |
| Leveraged | - |
| Inverse | - |
| Advisor Series | - |
| Covered Call Strategy | No |
The investment objective of the ETF is to seek to replicate, to the extent possible, the performance of the North American Marijuana Index, net of expenses. The North American Marijuana Index is designed to provide exposure to the performance of a basket of North American publicly listed companies with significant business activities in the marijuana industry.
To achieve HMMJ’s investment objectives, HMMJ invests and holds the equity securities of the Constituent Issuers in substantially the same proportion as its Underlying Index. These securities, which could include ADRs, will be listed on stock exchanges in North America, and will be equity securities of life sciences companies, and other companies, with significant business activities in the marijuana industry.
| Portfolio Manager |
Global X Investments Canada Inc. |
|---|---|
| Sub-Advisor |
- |
| Fund Manager |
Global X Investments Canada Inc. |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
TSX Trust Company |
| Distributor |
- |
| MER | 0.98% |
|---|---|
| Management Fee | 0.75% |
Try Fund Library Premium
For Free with a 30 day trial!
Fund Library
